|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02393 YESTAR HEALTH
Nominal 
0.078 -0.005 (-6.024%) | 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Turnover | 2,409,916 | -17.263% | 2,912,733 | 4,293,982 | 4,930,692 | 4,106,938 |
| Cost of Sales | (2,010,714) | -16.219% | (2,399,951) | (3,585,273) | (4,081,997) | (3,300,058) |
| Gross Profit | 399,202 | -22.150% | 512,782 | 708,709 | 848,695 | 806,880 |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (156,655) | -- | 38,837 | (142,004) | (7,321) | (25,279) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | 1,083,407 | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 19,731 | 7,994 | 5,247 | |
| Profit / (Loss) before Taxation | 929,643 | 2165.212% | 41,040 | (1,107,342) | 59,942 | (692,595) | |
| Taxation | (26,666) | -32.597% | (39,562) | 86,748 | (47,263) | 47,297 | |
| Profit / (Loss) from Discontinued Operations | 536 | -- | (2,749) | -- | -- | -- | |
| Non-controlling Interests | 18,101 | -- | (12,617) | 28,362 | (9,352) | 54,813 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 921,614 | -- | (13,888) | (992,232) | 3,327 | (590,485) | |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 28,674 | -82.335% | 162,318 | 292,996 | 160,942 | 112,729 |
| Depreciation & Amortisation | 79,715 | -1.599% | 81,010 | 230,776 | 232,905 | 251,251 |
| Directors' Emoluments | -- | -- | 7,062 | 7,371 | 12,035 | 10,694 |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified (Modified Report) | Disclaimer | Unqualified | Unqualified (Modified Report) |
Market Valuation Indicators
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | 39.530 | -- | -0.600 | -42.600 | 0.100 | -25.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.166 | (0.039) | 0.305 | 0.284 |
| NBV per share ($) | 0.198 | -- | (0.196) | (0.175) | 0.324 | 0.321 |
| Remarks: | Real time quote last updated: 22/04/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 921,614 |
| %Change | -- |
| EPS / (LPS) | RMB 0.395 |
| NBV Per Share (¥) | RMB 0.198 |